A 12-week, Multicenter, Randomized, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster NEXThaler (Beclomethasone Dipropionate 100 microg Plus Formoterol 6 microg/Actuation), 2 Inhalations b.i.d., Versus Seretide Accuhaler (Fluticasone 250 microg Plus Salmeterol 50 microg/Actuation), 1 Inhalation b.i.d., on Small Airway Derived Parameters in Patients With Asthma

Trial Profile

A 12-week, Multicenter, Randomized, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster NEXThaler (Beclomethasone Dipropionate 100 microg Plus Formoterol 6 microg/Actuation), 2 Inhalations b.i.d., Versus Seretide Accuhaler (Fluticasone 250 microg Plus Salmeterol 50 microg/Actuation), 1 Inhalation b.i.d., on Small Airway Derived Parameters in Patients With Asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Beclometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms NELSON
  • Sponsors Chiesi Farmaceutici SpA
  • Most Recent Events

    • 23 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Feb 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2013 to 1 Feb 2014.
    • 14 Feb 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top